Millendo Therapeutics: A Forgotten Biotech With Strong Potential [Seeking Alpha]
Millendo Therapeutics, Inc. - Common Stock (MLND)
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Millendo Therapeutics: A Forgotten Biotech With Strong Potential Summary Millendo Therapeutics expects to report results from its phase 2b/3 ZEPHYR study using livoletide to treat patients with prader-willi-syndrome in the first half of 2020. Preliminary data from a 14-day study was encouraging as patients treated with livoletide with prader-willi-syndrome achieved an improvement in HQ score over placebo. Top-line results from cohort 1 of a phase 2 study, using another drug nevanimibe treating patients with congenital adrenal hyperplasia, is expected 2nd half of 2020. Millendo has $48.3 million as of September 30, 2019, which is enough to fund its operations through Q4 of 2020. MLND Livoletide For Treatment Of Prader-Willi Syndrome The lead drug in the pipeline for Millendo is known as livoletide. It is being developed to treat patients with a very rare disease known as It is even said that it causes a major issue with patients being short. Therefore, they have to take growth hor
Show less
Read more
Impact Snapshot
Event Time:
MLND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MLND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MLND alerts
High impacting Millendo Therapeutics, Inc. - Common Stock news events
Weekly update
A roundup of the hottest topics